Placenta
Volume 29 , Pages 147-151 , October 2008

Breast Cancer and Fertility Preservation

  • G.L. Schattman

      Affiliations

    • The Center for Reproductive Medicine, Weill Cornell Medical College of Cornell University, 1305 York Avenue, 7th floor, NY 10021, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 646 962 3836.
    • ,
  • J. Navarro

      Affiliations

    • Victoria Eugenia Hospital, Operative Unit of Reproductive Medicine, Sevilla, Spain

,Accepted 12 August 2008.

References 

  1. American Cancer Society . Cancer facts and figures-2001. Atlanta, GA: American Cancer Society; 2001;
  2. Hankey BF, Miller B, Curtis R, Kosary C. Trends in breast cnacer in young women in contrast to older women. J Natl Cancer Inst Monogr. 1994;16:7–14
  3. Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials. Lancet. 2005;365:1687–1717
  4. Ries LAG, Percy CL, Bunin GR. Introduction. In:  Ries LAG,  Smith MA,  Gurney JG,  Linet M,  Tamra T,  Young JL, et al. editor. Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995 (NIH pub. No. 99-4649). Bethesda, MD: National Cancer Institute; 1999;p. 1–15
  5. Brown RJ, Davidson NE. Adjuvant hormonal therapy for premenopausal women with breast cancer. Semin Oncol. 2006;33:657–663
  6. Partridge AH, Gelber S, Peppercorn J, Sampson E, Knudsen K, Laufer M, et al. Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol. 2004;22:4174–4183
  7. Living beyond cancer. Finding a new balance, President's Cancer Panel 2003–2004 Annual Report, US Department of Health and Human Services, 2004; p. 1–87.
  8. Byrne J, Fears TR, Gail MH, Pee D, Connelly RR, Austin DF, et al. Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol. 1992;166:788–793
  9. Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update. 2001;7:535–543
  10. Hortobagyi GN, Buzdar AU, Marcus CE, Smith TL. Immediate and long-term toxicity of adjuvant chemotherapy regimens containing doxorubicin in trials at M.D. Anderson Hospital and Tumor Institute. NCI monogr. 1986;1:105–109
  11. Walshe JM, Denduluri N, Swain SM. Amenorrhea in pre-menopausal women after adjuvant chemotherapy for breast cancer. J Clin Oncol. 2006;24:5769–5779
  12. Ganz PA. Breast cancer, menopause and long-term survivorship: critical issues for the 21st century. Am J Med. 2005;118(Suppl. 12B):136–141
  13. Schmidt KL, Andersen CY, Loft A, Byskov AG, Ernst E, Anderson AN. Follow-up of ovarian function post-chemotherapy following ovarian cryopreservation and transplantation. Hum Reprod. 2005;20:3539–3546
  14. Dolmans MM, Demylle D, Martinez-Madrid B, Donnez J. Efficacy of in vitro fertilization after chemotherapy. Fertil Steril. 2005;83:897–901
  15. Wallace WHB, Thomson AB, Kelsey TW. The radiosensitivity of the human oocyte. Hum Reprod. 2003;18:117–121
  16. Wallace WH, Thomson AB, Saran F, Kelsey TW. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys. 2005;62:738–744
  17. Urbano MT, Tait DM. Can the irradiated uterus sustain a pregnancy? A literature review. Clin Oncol (R Coll Radiol). 2004;16:24–28
  18. Falcone T, Bedaiwy MA. Fertility preservation and pregnancy outcome after malignancy. Curr Opin Obstet Gynecol. 2005;17:21–26
  19. Meduri G, Touraine P, Beau I, Lahuna O, Desroches A, Vacher-Lavenu MC, et al. Delayed puberty and primary amenorrhea associated with a novel mutation of the human follicle-stimulating hormone receptor:clinical, histological and molecular studies. J Clin Endocrinol Metab. 2003;88:3491–3498
  20. Teinturier C, Hartmann O, Valteau-Coauanet D, Benhamou E, Bougneres PF. Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure. Bone Marrow Transplant. 1998;22:989–994
  21. Sonmezer M, Oktay K. Fertility preservation in female patients. Hum Reprod Update. 2004;10:251–266
  22. Huser M, Crha I, Ventruba P, Hudecek R, Zakova J, Smardova L, et al. Prevention of ovarian function damage by a GnRH analogue during chemotherapy in Hodgkin lymphoma patients. Hum Reprod. 2008;23:863–868
  23. Waxman JH, Ahmed R, Smith D, Wrigley PFM, Gregory W, Shalet S, et al. Failure to preserve fertility in patients with Hodgkin's disease. Cancer Chemother Pharmacol. 1987;19:159–162
  24. Oktay K, Cil AP, Bang H. Efficiency of oocyte cryopreservation: a meta-analysis. Fertil Steril. 2006;86:70–80
  25. Shaw JM, Oranratnachai A, Trounson AO. Fundamental cryobiology of mammalian oocytes and ovarian tissue. Theriogenology. 2000;53:59–72
  26. Baka SG, Toth TL, Veeck LL, Jones HW, Muasher SJ, Lazendorf SE. Evaluation of the spindle apparatus of in-vitro matured human oocytes following cryopreservation. Hum Reprod. 1995;10:1816–1820
  27. The Practice Committee of the American Society of Reproductive Medicine . Ovarian tissue and oocyte cryopreservation. Fertil Steril. 2006;86:S142–S147
  28. Jurema M, Noguire D. In vitro maturation of human oocytes for assisted reproduction. Fertil Steril. 2006;86:1277–1291
  29. Prichard RS, Hill AD, Dijkstra B, McDermott EW, O'Higgins NJ. The prevention of breast cancer. Br J Surg. 2003;90:772–783
  30. Steiner AZ, Terplan M, Paulson R. Comparison of tamoxifen and clomiphene citrate for ovulation induction: a meta-analysis. Hum Reprod. 2005;20:1511–1515
  31. Oktay K, Buyuk E, Davis O, Yermakova I, Veeck L, Rosenwaks Z. Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum Reprod. 2003;18:90–95
  32. Shushan A, Peretz T, Mor-Yosef S. Therapeutic approaches to ovarian cysts in tamoxifen-treated women with breast cancer. Int J Gynaecol Obstet. 1996;52:249–253
  33. Klijn JG, Beex LV, Mauriac L. Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: a randomized study. J Natl Cancer Inst. 2000;92:903–911
  34. Pfister CU, Martoni A, Zamagni C, Lelli G, De Braud F, Souppart C, et al. Effects of age and single versus multiple dose pharmacokinetics of letrozole (femara) in breast cancer patients. Biopharm Drug Dispos. 2001;22:191–197
  35. Casper RF. Aromatase inhibitors in ovarian stimulation. J Steroid Biochem Mol Biol. 2007;106:71–75
  36. Oktay K, Buyuk E, Libertella N, Akar M, Rosenwaks Z. Fertility preservation in breast cancer patients: a prospective controlled comparison with ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol. 2005;23:4347–4353
  37. Radford JA, Lieberman BA, Brison DR, Smith ARB, Critchlow JD, Russell SA, et al. Orthotopic reimplantation of cryopreserved ovarian cortical strips after high-dose chemotherapy for Hodgkin's lymphoma. Lancet. 2001;357:1172–1175
  38. Oktay K, Karlikaya G. Ovarian function after transplantation of frozen, banked autologous ovarian tissue. N Engl J Med. 2000;342:1919
  39. Donnez J, Dolmans MM, Demylle D, Jadoul P, Squifflet J, Martinez-Madrid B, et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004;364:1405–1410
  40. Meirow D, Levron J, Eldar-Geva T, Hardan I, Fridman E, Zalel Y, et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med. 2005;353:318–321
  41. Telfer EE, McLaughlin M, Ding C, Thong KJ. A two-step serum-free culture system supports development of human oocytes from primordial follicles in the presence of activin. Hum Reprod. 2008;23:1151–1158
  42. Curtin JP, Barakat RR, Hoskins WJ. Ovarian disease in women with breast cancer. Obstet Gynecol. 1994;84:449–452

PII: S0143-4004(08)00258-0

doi: 10.1016/j.placenta.2008.08.012

Placenta
Volume 29 , Pages 147-151 , October 2008

Article Tools